Published in Methods Mol Biol on January 01, 2011
Lipid body-phagosome interaction in macrophages during infectious diseases: host defense or pathogen survival strategy? PLoS Pathog (2012) 1.04
Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation. J Immunol (2011) 0.91
Lipid droplets in leukocytes: Organelles linked to inflammatory responses. Exp Cell Res (2015) 0.84
Lipid bodies: inflammatory organelles implicated in host-Trypanosoma cruzi interplay during innate immune responses. Mediators Inflamm (2012) 0.83
Unraveling the complexity of lipid body organelles in human eosinophils. J Leukoc Biol (2014) 0.82
Lipid Body Organelles within the Parasite Trypanosoma cruzi: A Role for Intracellular Arachidonic Acid Metabolism. PLoS One (2016) 0.81
A snake venom group IIA PLA2 with immunomodulatory activity induces formation of lipid droplets containing 15-d-PGJ2 in macrophages. Sci Rep (2017) 0.75
Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem (2000) 8.86
A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell (1995) 7.99
The PPARalpha-leukotriene B4 pathway to inflammation control. Nature (1996) 5.14
Lipid signalling in disease. Nat Rev Mol Cell Biol (2008) 4.85
Mycobacterium bovis bacillus Calmette-Guérin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J Immunol (2006) 1.87
Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res (2008) 1.45
Leukocyte lipid bodies - Biogenesis and functions in inflammation. Biochim Biophys Acta (2009) 1.44
Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7. Proc Natl Acad Sci U S A (2003) 1.30
Phospholipase A(2). Prostaglandins Leukot Essent Fatty Acids (2003) 1.27
Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. J Immunol (2002) 1.22
Extranuclear lipid bodies, elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils. J Biol Chem (2001) 1.21
Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis. J Biol Chem (2006) 1.20
Fatty acids as gatekeepers of immune cell regulation. Trends Immunol (2003) 1.14
The membrane organization of leukotriene synthesis. Proc Natl Acad Sci U S A (2004) 1.13
Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion. J Exp Med (2002) 1.13
Intracellular compartmentalization of leukotriene synthesis: unexpected nuclear secrets. FEBS Lett (2001) 1.10
The cellular biology of eosinophil eicosanoid formation and function. J Allergy Clin Immunol (2002) 1.08
Release of prostaglandin E2 by microfilariae of Wuchereria bancrofti and Brugia malayi. Am J Trop Med Hyg (1992) 1.01
IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling. J Immunol (2002) 1.00
Eosinophils and cysteinyl leukotrienes. Prostaglandins Leukot Essent Fatty Acids (2003) 0.99
Cytosolic phospholipase A2-driven PGE2 synthesis within unsaturated fatty acids-induced lipid bodies of epithelial cells. Biochim Biophys Acta (2009) 0.99
Lipid bodies in oxidized LDL-induced foam cells are leukotriene-synthesizing organelles: a MCP-1/CCL2 regulated phenomenon. Biochim Biophys Acta (2009) 0.99
Allergic challenge-elicited lipid bodies compartmentalize in vivo leukotriene C4 synthesis within eosinophils. Am J Respir Cell Mol Biol (2005) 0.95
Cutting edge: prostaglandin D2 enhances leukotriene C4 synthesis by eosinophils during allergic inflammation: synergistic in vivo role of endogenous eotaxin. J Immunol (2006) 0.92
Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med (2008) 5.94
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol (2009) 3.74
Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol (2006) 3.04
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol (2012) 2.78
Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol (2010) 2.74
Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog (2009) 2.52
Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis (2008) 2.08
Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol (2010) 2.04
Lipid droplet formation in leprosy: Toll-like receptor-regulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis. J Leukoc Biol (2009) 1.89
Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J Leukoc Biol (2008) 1.79
Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells. J Immunol (2007) 1.78
Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood (2013) 1.74
Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules. J Allergy Clin Immunol (2010) 1.72
Roles and origins of leukocyte lipid bodies: proteomic and ultrastructural studies. FASEB J (2006) 1.71
Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. Traffic (2005) 1.56
Pivotal advance: eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production. J Leukoc Biol (2008) 1.55
Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. Proc Natl Acad Sci U S A (2006) 1.54
Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments. Traffic (2005) 1.52
Methylprednisolone improves lung mechanics and reduces the inflammatory response in pulmonary but not in extrapulmonary mild acute lung injury in mice. Crit Care Med (2008) 1.49
Clinical overview of hypereosinophilic syndromes. Immunol Allergy Clin North Am (2007) 1.47
Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res (2008) 1.45
Leukocyte lipid bodies - Biogenesis and functions in inflammation. Biochim Biophys Acta (2009) 1.44
Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7. Proc Natl Acad Sci U S A (2003) 1.30
Eosinophil granules function extracellularly as receptor-mediated secretory organelles. Proc Natl Acad Sci U S A (2008) 1.30
Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. J Appl Physiol (1985) (2005) 1.24
Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins. J Leukoc Biol (2007) 1.23
Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. J Immunol (2002) 1.22
Eosinophils and Th2 immunity: contemporary insights. Immunol Cell Biol (2010) 1.22
Eosinophilic pneumonias. Clin Microbiol Rev (2012) 1.20
Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol (2010) 1.19
Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog (2010) 1.18
Lipid bodies in inflammatory cells: structure, function, and current imaging techniques. J Histochem Cytochem (2011) 1.17
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field. Expert Rev Hematol (2012) 1.15
Calcitonin gene-related peptide inhibits local acute inflammation and protects mice against lethal endotoxemia. Shock (2005) 1.14
Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion. J Exp Med (2002) 1.13
Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD). J Allergy Clin Immunol (2012) 1.12
Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria. PLoS Pathog (2012) 1.11
Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans. Blood (2013) 1.09
The cellular biology of eosinophil eicosanoid formation and function. J Allergy Clin Immunol (2002) 1.08
Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism. J Biol Chem (2007) 1.08
Vesicle-mediated secretion of human eosinophil granule-derived major basic protein. Lab Invest (2009) 1.07
Modulation of lipid droplets by Mycobacterium leprae in Schwann cells: a putative mechanism for host lipid acquisition and bacterial survival in phagosomes. Cell Microbiol (2010) 1.07
Eosinophils and disease pathogenesis. Semin Hematol (2012) 1.05
EliCell assay for the detection of released cytokines from eosinophils. J Immunol Methods (2003) 1.05
Dengue virus capsid protein binding to hepatic lipid droplets (LD) is potassium ion dependent and is mediated by LD surface proteins. J Virol (2011) 1.04
Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses. Histol Histopathol (2010) 1.03
TLR6-driven lipid droplets in Mycobacterium leprae-infected Schwann cells: immunoinflammatory platforms associated with bacterial persistence. J Immunol (2011) 1.03
Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis. J Infect Dis (2006) 1.03
Functional extracellular eosinophil granules: novel implications in eosinophil immunobiology. Curr Opin Immunol (2009) 1.03
Novel targeted therapies for eosinophilic disorders. J Allergy Clin Immunol (2012) 1.02
Cutting edge: bradykinin induces IL-12 production by dendritic cells: a danger signal that drives Th1 polarization. J Immunol (2003) 1.01
Cytokine-associated angioedema syndromes including episodic angioedema with eosinophilia (Gleich's Syndrome). Immunol Allergy Clin North Am (2006) 1.01
IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling. J Immunol (2002) 1.00
Eosinophils and cysteinyl leukotrienes. Prostaglandins Leukot Essent Fatty Acids (2003) 0.99
Cytosolic phospholipase A2-driven PGE2 synthesis within unsaturated fatty acids-induced lipid bodies of epithelial cells. Biochim Biophys Acta (2009) 0.99
Lipid bodies in oxidized LDL-induced foam cells are leukotriene-synthesizing organelles: a MCP-1/CCL2 regulated phenomenon. Biochim Biophys Acta (2009) 0.99
Leptin and mTOR: partners in metabolism and inflammation. Cell Cycle (2008) 0.98
Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils. J Allergy Clin Immunol (2002) 0.98
Lipid bodies in innate immune response to bacterial and parasite infections. Int Immunopharmacol (2008) 0.97
Cutaneous periumbilical purpura in disseminated strongyloidiasis in cancer patients: a pathognomonic feature of potentially lethal disease? Braz J Infect Dis (2006) 0.97
Allergic challenge-elicited lipid bodies compartmentalize in vivo leukotriene C4 synthesis within eosinophils. Am J Respir Cell Mol Biol (2005) 0.95
Subcellular fractionation of human eosinophils: isolation of functional specific granules on isoosmotic density gradients. J Immunol Methods (2009) 0.94
Mature human eosinophils express functional Notch ligands mediating eosinophil autocrine regulation. Blood (2009) 0.94
Mycobacterium leprae intracellular survival relies on cholesterol accumulation in infected macrophages: a potential target for new drugs for leprosy treatment. Cell Microbiol (2014) 0.93
Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia? Am J Respir Crit Care Med (2003) 0.93
Cutting edge: prostaglandin D2 enhances leukotriene C4 synthesis by eosinophils during allergic inflammation: synergistic in vivo role of endogenous eotaxin. J Immunol (2006) 0.92
Eosinophils as antigen-presenting cells in allergic upper airway disease. Curr Opin Allergy Clin Immunol (2010) 0.92
The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif. Biochem J (2012) 0.92
Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. J Immunol (2002) 0.92
The internal architecture of leukocyte lipid body organelles captured by three-dimensional electron microscopy tomography. PLoS One (2013) 0.91
Circulating levels of macrophage migration inhibitory factor are associated with mild pulmonary dysfunction after cardiopulmonary bypass. Shock (2004) 0.91
Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation. J Immunol (2011) 0.91
Leukocyte lipid bodies: inflammation-related organelles are rapidly detected by wet scanning electron microscopy. J Lipid Res (2006) 0.90
Eosinophils: offenders or general bystanders in allergic airway disease and pulmonary immunity? J Innate Immun (2011) 0.90
Electron tomography and immunonanogold electron microscopy for investigating intracellular trafficking and secretion in human eosinophils. J Cell Mol Med (2008) 0.90
Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol (2005) 0.89
Intravenous glutamine decreases lung and distal organ injury in an experimental model of abdominal sepsis. Crit Care (2009) 0.89
CCL11 elicits secretion of RNases from mouse eosinophils and their cell-free granules. FASEB J (2012) 0.89
Schistosomal‐derived lysophosphatidylcholine are involved in eosinophil activation and recruitment through Toll‐like receptor-2-dependent mechanisms. J Infect Dis (2010) 0.89
Cross-talk between macrophage migration inhibitory factor and eotaxin in allergic eosinophil activation forms leukotriene C₄-synthesizing lipid bodies. Am J Respir Cell Mol Biol (2010) 0.88
ICON: Eosinophil Disorders. World Allergy Organ J (2012) 0.88
Imaging lipid bodies within leukocytes with different light microscopy techniques. Methods Mol Biol (2011) 0.88
PPARγ Expression and Function in Mycobacterial Infection: Roles in Lipid Metabolism, Immunity, and Bacterial Killing. PPAR Res (2012) 0.87
Activated human eosinophils. Int Arch Allergy Immunol (2005) 0.87
Contributions of electron microscopy to understand secretion of immune mediators by human eosinophils. Microsc Microanal (2010) 0.86
Turnover of neutrophils mediated by Fas ligand drives Leishmania major infection. J Infect Dis (2005) 0.86
Mechanisms of eosinophil cytokine release. Mem Inst Oswaldo Cruz (2005) 0.86
Advances in diagnosis and treatment of eosinophilia. Curr Opin Hematol (2009) 0.86
Interplay of cysteinyl leukotrienes and TGF-β in the activation of hepatic stellate cells from Schistosoma mansoni granulomas. Biochim Biophys Acta (2010) 0.85
Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway. Cell Cycle (2012) 0.84
Deciphering the contribution of lipid droplets in leprosy: multifunctional organelles with roles in Mycobacterium leprae pathogenesis. Mem Inst Oswaldo Cruz (2012) 0.83
MHC Class II and CD9 in human eosinophils localize to detergent-resistant membrane microdomains. Am J Respir Cell Mol Biol (2011) 0.83
Isolation of human eosinophils. Curr Protoc Immunol (2012) 0.82
Anti-allergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influx. Int Immunopharmacol (2005) 0.81
Eosinophil crystalloid granules: structure, function, and beyond. J Leukoc Biol (2012) 0.80
Clinical problem-solving. The writing on the wall. N Engl J Med (2009) 0.80